Skip to content
JLM-BioCity
  • HOME
  • ABOUT US
    • What is JLM-BioCity?
    • What We Do
    • Board of Advisors
    • Meet the Team
  • EVENTS
    • Past Events
    • Event Clips
  • RESOURCES
    • JLM Bio Innovation
    • JLM Companies
    • JLM Landscape
    • BioTips
    • Blog
    • Briefs
  • JOIN US
    • Our Partners
    • Become a Partner
  • CONTACT US
Menu Close
  • HOME
  • ABOUT US
    • What is JLM-BioCity?
    • What We Do
    • Board of Advisors
    • Meet the Team
  • EVENTS
    • Past Events
    • Event Clips
  • RESOURCES
    • JLM Bio Innovation
    • JLM Companies
    • JLM Landscape
    • BioTips
    • Blog
    • Briefs
  • JOIN US
    • Our Partners
    • Become a Partner
  • CONTACT US

JLM-BioCity Innovations

  1. Home>
  2. Resources>
  3. JLM-BioCity Innovations>
  4. Page 23

Augmedics Announces U.S. Launch of xvision, First Augmented Reality Surgery Guidance System

December 30, 2019

Augmedics, a pioneer in augmented reality surgical image guidance, has announced U.S. Food and Drug Administration (FDA) 510(k) clearance and the U.S. launch of its

Read More »

Novelstem Increases Newstem Ownership to 27.3%

December 30, 2019

Following achievement of an important milestone for Stem-Cell based cancer treatments resistance diagnostics, Jerusalem based NewStem received a further $ 1 million follow-on investment from

Read More »

Fat Melting Pharmaceutical Company Raziel Therapeutics Raises $22 Million

December 30, 2019

Raziel Therapeutics a clinical-stage pharmaceutical company announces a $22 million Series C preferred stock financing led by Pontifax, with the participation of existing investors Dr. Shmuel Cabilly

Read More »

Concenter Biopharma Ltd. is developing a Promising Drug for Treating and Preventing Type 2 Diabetes (T2D)

November 29, 2019

Concenter Biopharma is working on a novel drug to eliminate type 2 diabetes with no side effects. The drug dramatically lowers insulin resistance, the major

Read More »

SaliStick of Salignostics-the World’s First Saliva Rapid Pregnancy Test at Medica Expo, Germany

November 29, 2019

During the MEDICA exhibition in Düsseldorf, Germany, on November 18, Salignostics present for the first time the world’s first saliva rapid pregnancy test, the SaliStick. Salistick provides

Read More »

Entera Bio recently entered into a $270 million license agreement with Amgen

November 10, 2019

Entera Bio‘s platform technology enables oral therapies based on molecules that would otherwise undergo gastric degradation and have limited or no bioavailability. By transforming injectable

Read More »

Pepticom Raises $5 million in Series A Funding

November 10, 2019

Jerusalem based Pepticom, a leader in artificial intelligence peptide drug discovery,  has secured $5 million in Series A funding from the Chartered Group. Pepticom’s unique

Read More »

Gamida Cell and Lonza Establish Commercial Manufacturing Agreement for Omidubicel

November 10, 2019

Jerusalem-based Gamida Cell Ltd. (Nasdaq: GMDA), a leading cellular and immune therapeutics company, and Swiss Lonza (SWX: LONN), an integrated healthcare solutions provider, have entered into a strategic

Read More »

Accellix signs Co-Development Agreement with Orgenesis

October 28, 2019

Agreement Integrates Accellix’s Proprietary Quality Control Optic System, Cartridges, Reagents and Software into Orgenesis’ Point of Care Cellular Therapy Platform Orgenesis Inc. a leading cell

Read More »
« Previous Page1 Page2 Page3 Page4 Page5 Page6 Page7 Page8 Page9 Page10 Page11 Page12 Page13 Page14 Page15 Page16 Page17 Page18 Page19 Page20 Page21 Page22 Page23 Page24 Page25 Page26 Page27 Page28 Page29 Page30 Page31 Page32 Page33 Page34 Page35 Page36 Page37 Page38 Page39 Page40 Page41 Page42 Next »

JLM-BioCity Upcoming Events

More JLM-BioCity events coming soon…

What People Say About JLM-BioCity

Alexander Naslednikov

JLM-BioCity Member Alexander Naslednikov

Excellent organization (from the timing to food), the quality of the audience was superior, we personally got a lot of hot leads.

-Alexander Naslednikov, Founder and CEO, Med.me

Tal Or

JLM-BioCity Member Tal Or

One of the best meetups organizations and a very important source of information and connections for startups.

-Tal Or, Co-Founder, ATLASense Biomed Ltd.

Hemda Idel

JLM BioCity Member Hemda Idel

Very informative and eye-opening event. Thank you for the great hospitality.

– Hemda Idel, founder, SLEEP ASAP

Aviv Marom

JLM BioCity Member Aviv Marom

There was an excellent networking atmosphere with impressive Panelists as well as high-quality audience participants. I strongly recommend paying attention to future events.

-Aviv Marom, Director, Strategic Partnerships, Samsung Research, Israel

Aurélie Schwarzbach

Such an interesting lecture and great people attending!

– Aurélie Schwarzbach, Clinical Project Manager, Gamida Cell Ltd.

Zeev Malyutin

Thank you all for the great evening, it was a pleasure to see such a good and diverse set of Biomed minded people in Jerusalem!

– Zeev Malyutin, Protein Department Head, Merck KGaA

Gideon Silberman

JLM BioCity Member Gideon Silberman

Excellent event. Good speakers, interesting audience. Well done!

– Gideon Silberman, Director of Business Development, Partner and Co-Founder, Aneeva.com

Immanuel Lerner

Immanuel Lerner CEO, Pepticom

I believe in the idea of JLM-BioCity. It is good that there is an organization that represents the life science companies in Jerusalem and provides an excellent platform for networking through its regular meetings.

– Immanuel Lerner CEO, Pepticom

Dror Chevion

Dror Chevion Concenter BioPharma

JLM-BioCity’s events are well organized with a professional approach. You can feel a “homey” atmosphere around the people of a well-maintained bio-community in Jerusalem. Team members always make sure the guests feel welcome and connected to the right people for possible collaborations. There are clearly visible good-will and dedication to lead the members of the bio-community and the city as a whole to success.

– Dror Chevion  CEO, Concenter BioPharma

Ian Solomon

Ian Solomon CTO, OmnySense Ltd

The JLM BioCity networking events on Zoom keeps getting better.  For OmnySense they have provided an excellent forum in which to present our company, and the break-out sessions facilitate direct discussion with a broad range of potential partners and investors.

-Ian Solomon CTO, OmnySense Ltd.

Moshe Lebowitz

Moshe Lebowitz with Jerusalem Mayor Moshe Leon - Credit Dr George Lowell

Because every biotech and medtech professional knows that Jerusalem BioCity consistently delivers world-class programming, the best professionals always show up and the networking before and after the events is worth its time in gold.

– Moshe Lebowitz, CEO, Healables Digital Health | Healables: Wearables that Heal

JLM-BioCity in THE MARKER

JLM-BioCity was recently written up in THE MARKER (in Hebrew). To see the article, click here.

Strategic Partners

Platinum

Gold

Silver

JLM-BIOCITY is a division of the Jerusalem Business Networking Forum (JBNF)

Contact us at

+972-(0)54-973-0029

info at jlm-biocity.org

Follow us

Linkedin Facebook-f Youtube

Home

About

What’s Happening

Resources

Become a Partner

Become a Member

JLM-BioSynergy

Contact Us

Copyright © 2020 JLM-BioCity | All rights reserved